India's Gland Pharma up after USFDA inspection shows zero observations

Gland Pharma

31/07/2023 05:04

** Shares of Gland Pharma  GLAD.NS  up as much as 8% to 1,393.95
rupees, highest since May 12
    ** Stock on track for a third consecutive session of gains
if trends hold
    ** Co on Friday said the USFDA conducted a good
manufacturing practice inspection at its VSEZ Sterile Oncology
Facility in Visakhapatnam
    ** The inspection closed with zero observations for form 483
and a classification of no action indicated
    ** More than 514,000 shares change hands by 9:28 a.m. IST vs
30-day avg of 781,209 shares
    ** As of last close, stock down 18.1% YTD

 (Reporting by Navamya Ganesh Acharya in Bengaluru)
 ((Navamya.GaneshAcharya@thomsonreuters.com; +91 8805175330 ;))